Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Schizophrenia

Free Subscription 16.09.2019 1 Acta Psychiatr Scand 1 Am J Med Genet B Neuropsychiatr Genet 2 Am J Psychiatry 5 Biol Psychiatry 1 J Clin Psychiatry 1 J Int Neuropsychol Soc 7 J Nerv Ment Dis 1 Mol Psychiatry 1 Neurosci Lett 1 PLoS Genet 1 PLoS One 5 Psychiatry Res 4 Psychol Med 7 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Psychiatr Scand

1. GEROS H, Sizer H, Mifsud N, Reynolds S, et al
   Migrant status and identification as ultra-high risk for psychosis and transitioning to a psychotic disorder.
   Acta Psychiatr Scand. 2019 Sep 14. doi: 10.1111/acps.13099.
   PubMed     Text format     Abstract available
   
   

   
   Am J Med Genet B Neuropsychiatr Genet

2. MYINT L, Wang R, Boukas L, Hansen KD, et al
   A screen of 1,049 schizophrenia and 30 Alzheimer's-associated variants for regulatory potential.
   Am J Med Genet B Neuropsychiatr Genet. 2019 Sep 10. doi: 10.1002/ajmg.b.32761.
   PubMed     Text format     Abstract available
   
   

   
   Am J Psychiatry

3. DUGRE JR, Bitar N, Dumais A, Potvin S, et al
   Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind.
   Am J Psychiatry. 2019 Sep 6:appiajp201919030247.
   PubMed     Text format     Abstract available
   
   
4. ALLSWEDE DM, Addington J, Bearden CE, Cadenhead KS, et al
   Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains.
   Am J Psychiatry. 2019 Sep 6:appiajp201918111290.
   PubMed     Text format     Abstract available
   
   

   
   Biol Psychiatry

5. KAMINSKI J, Gleich T, Fukuda Y, Katthagen T, et al
   Association of Cortical Glutamate and Working Memory Activation in Patients With Schizophrenia: A Multimodal Proton Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study.
   Biol Psychiatry. 2019 Jul 26. pii: S0006-3223(19)31544.
   PubMed     Text format     Abstract available
   
   
6. FOSS-FEIG JH
   Looking Under the Hood of Convergent Behavioral Deficits in Schizophrenia and Autism.
   Biol Psychiatry. 2019;86:e21-e23.
   PubMed     Text format    
   
   
7. WESTLYE LT, Alnaes D, van der Meer D, Kaufmann T, et al
   Population-Based Mapping of Polygenic Risk for Schizophrenia on the Human Brain: New Opportunities to Capture the Dimensional Aspects of Severe Mental Disorders.
   Biol Psychiatry. 2019;86:499-501.
   PubMed     Text format    
   
   
8. SHEKHAR A
   Role of Kappa Opioid Receptors in Symptoms of Schizophrenia: What Is the Neurobiology?
   Biol Psychiatry. 2019;86:494-496.
   PubMed     Text format    
   
   
9. FORSYTH JK, Nachun D, Gandal MJ, Geschwind DH, et al
   Synaptic and Gene Regulatory Mechanisms in Schizophrenia, Autism, and 22q11.2 Copy Number Variant-Mediated Risk for Neuropsychiatric Disorders.
   Biol Psychiatry. 2019 Jul 11. pii: S0006-3223(19)31514.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Psychiatry

10. MUSTAFA S, Joober R, Iyer S, Shah J, et al
    Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available
    
    

    
    J Int Neuropsychol Soc

11. BECHI M, Agostoni G, Buonocore M, Bosinelli F, et al
    The Influence of Premorbid Adjustment and Autistic Traits on Social Cognitive Dysfunction in Schizophrenia.
    J Int Neuropsychol Soc. 2019 Sep 11:1-10. doi: 10.1017/S1355617719000961.
    PubMed     Text format     Abstract available
    
    

    
    J Nerv Ment Dis

12. ALHERZ M, Almusawi H, Barry DS
    Diglossia in the Etiology of Schizophrenia: A Hypothesis.
    J Nerv Ment Dis. 2019 Sep 9. doi: 10.1097/NMD.0000000000001067.
    PubMed     Text format     Abstract available
    
    
13. ESCELSIOR A, Belvederi Murri M, Calcagno P, Cervetti A, et al
    Effectiveness of Cerebellar Circuitry Modulation in Schizophrenia: A Systematic Review.
    J Nerv Ment Dis. 2019 Sep 9. doi: 10.1097/NMD.0000000000001064.
    PubMed     Text format     Abstract available
    
    
14. UROSEVIC S, Halverson T, Sponheim SR
    Personality and the Expression of Symptomatology in Schizophrenia and Bipolar Disorder.
    J Nerv Ment Dis. 2019 Sep 9. doi: 10.1097/NMD.0000000000001060.
    PubMed     Text format     Abstract available
    
    
15. MOURA BM, Avila A, Chendo I, Frade P, et al
    Facilitating the Delivery of Cognitive Remediation in First-Episode Psychosis: Pilot Study of a Home-Delivered Web-Based Intervention.
    J Nerv Ment Dis. 2019 Sep 9. doi: 10.1097/NMD.0000000000001055.
    PubMed     Text format     Abstract available
    
    
16. NA EJ, Choi KW, Hong JP, Cho MJ, et al
    Paranoid Ideation Without Psychosis Is Associated With Depression, Anxiety, and Suicide Attempts in General Population.
    J Nerv Ment Dis. 2019 Sep 9. doi: 10.1097/NMD.0000000000001050.
    PubMed     Text format     Abstract available
    
    
17. OGAWA Y, Fukuhara K, Tanaka H, Nagata Y, et al
    Insight Into Illness and Defense Styles in Schizophrenia.
    J Nerv Ment Dis. 2019 Sep 9. doi: 10.1097/NMD.0000000000001038.
    PubMed     Text format     Abstract available
    
    
18. YBARRA ML, Rodriguez K, Madison H, Mojtabai R, et al
    Developing Texting for Relapse Prevention: A Scalable mHealth Program for People With Schizophrenia and Schizoaffective Disorder.
    J Nerv Ment Dis. 2019 Sep 9. doi: 10.1097/NMD.0000000000001037.
    PubMed     Text format     Abstract available
    
    

    
    Mol Psychiatry

19. CETIN-KARAYUMAK S, Di Biase MA, Chunga N, Reid B, et al
    White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study.
    Mol Psychiatry. 2019 Sep 11. pii: 10.1038/s41380-019-0509.
    PubMed     Text format     Abstract available
    
    

    
    Neurosci Lett

20. LIANG S, Chen S, Zhao L, Miao D, et al
    Categorization of emotional faces in schizophrenia patients: an ERP study.
    Neurosci Lett. 2019 Sep 10:134493. doi: 10.1016/j.neulet.2019.134493.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

21. SUN R, Hui S, Bader GD, Lin X, et al
    Powerful gene set analysis in GWAS with the Generalized Berk-Jones statistic.
    PLoS Genet. 2019;15:e1007530.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

22. VAN DER LEE APM, de Haan L, Beekman ATF
    Rising co-payments coincide with unwanted effects on continuity of healthcare for patients with schizophrenia in the Netherlands.
    PLoS One. 2019;14:e0222046.
    PubMed     Text format     Abstract available
    
    

    
    Psychiatry Res

23. GARCIA-FERNANDEZ L, Cabot-Ivorra N, Rodriguez-Garcia V, Perez-Martin J, et al
    Computerized cognitive remediation therapy, REHACOM, in first episode of schizophrenia: A randomized controlled trial.
    Psychiatry Res. 2019;281:112563.
    PubMed     Text format     Abstract available
    
    
24. ENGEN MJ, Simonsen C, Melle I, Faerden A, et al
    Cognitive functioning in patients with first-episode psychosis stratified by level of negative symptoms: A 1-year follow-up study.
    Psychiatry Res. 2019;281:112554.
    PubMed     Text format     Abstract available
    
    
25. FANG X, Chen L, Wang D, Yu L, et al
    Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia.
    Psychiatry Res. 2019;281:112522.
    PubMed     Text format     Abstract available
    
    
26. NYBOE L, Lemcke S, Moller AV, Stubbs B, et al
    Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review.
    Psychiatry Res. 2019;281:112556.
    PubMed     Text format     Abstract available
    
    
27. GORWOOD P, Bouju S, Deal C, Gary C, et al
    Predictive factors of functional remission in patients with early to mid-stage schizophrenia treated by long acting antipsychotics and the specific role of clinical remission.
    Psychiatry Res. 2019;281:112560.
    PubMed     Text format     Abstract available
    
    

    
    Psychol Med

28. HERNIMAN SE, Allott K, Phillips LJ, Wood SJ, et al
    Depressive psychopathology in first-episode schizophrenia spectrum disorders: a systematic review, meta-analysis and meta-regression.
    Psychol Med. 2019 Sep 16:1-12. doi: 10.1017/S0033291719002344.
    PubMed     Text format     Abstract available
    
    
29. BOJESEN KB, Ebdrup BH, Jessen K, Sigvard A, et al
    Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naive patients with psychosis.
    Psychol Med. 2019 Sep 16:1-12. doi: 10.1017/S0033291719002277.
    PubMed     Text format     Abstract available
    
    
30. GUO JY, Niendam TA, Auther AM, Carrion RE, et al
    Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Psychol Med. 2019 Sep 11:1-10. doi: 10.1017/S0033291719002332.
    PubMed     Text format     Abstract available
    
    
31. DWYER K, David AS, McCarthy R, McKenna P, et al
    Linguistic alignment and theory of mind impairments in schizophrenia patients' dialogic interactions.
    Psychol Med. 2019 Sep 10:1-9. doi: 10.1017/S0033291719002289.
    PubMed     Text format     Abstract available
    
    

    
    Schizophr Res

32. NGUYEN T, Seiler N, Maguire J, Sizer H, et al
    Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines.
    Schizophr Res. 2019 Sep 4. pii: S0920-9964(19)30383.
    PubMed     Text format    
    
    
33. TANDON N, Tandon R
    Using machine learning to explain the heterogeneity of schizophrenia. Realizing the promise and avoiding the hype.
    Schizophr Res. 2019 Sep 6. pii: S0920-9964(19)30388.
    PubMed     Text format     Abstract available
    
    
34. WALTHER S, Alexaki D, Stegmayer K, Vanbellingen T, et al
    Conceptual disorganization impairs hand gesture performance in schizophrenia.
    Schizophr Res. 2019 Sep 7. pii: S0920-9964(19)30393.
    PubMed     Text format    
    
    
35. WEI Y, Wang X, Wang Y, Qiu B, et al
    Functional magnetic resonance imaging in a single schizophrenia patient with voluntary control over auditory verbal hallucinations.
    Schizophr Res. 2019 Sep 12. pii: S0920-9964(19)30394.
    PubMed     Text format    
    
    
36. KEGELES LS, Ciarleglio A, Leon-Ortiz P, Reyes-Madrigal F, et al
    An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate (1)H MRS.
    Schizophr Res. 2019 Sep 12. pii: S0920-9964(19)30413.
    PubMed     Text format     Abstract available
    
    
37. HOWELL KR, Law AJ
    Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.
    Schizophr Res. 2019 Sep 12. pii: S0920-9964(19)30392.
    PubMed     Text format     Abstract available
    
    
38. LI H, Ou Y, Liu F, Chen J, et al
    Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: A global-brain functional connectivity analysis.
    Schizophr Res. 2019 Sep 12. pii: S0920-9964(19)30395.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: